Poole Jonathan bought ACAD
March 3, 2026 · Form 4 insider transaction
Poole Jonathan bought 2,010 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 17 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,010
Price
$0.00
Total value
N/A
InsiderPoole Jonathan
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 20, 2026
Shares owned after2,010
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.; The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.